| Application no. and date | 00923156.4 (espacenet) (Federated) (European Patent Register), 20000407 | | Patent/reg. no. and date | DK/EP 1169059, 20051026 | | Publication date | 20020109 | | Priority no. and date | US 128564 P, 19990409 | | EP pub. no. and date |
EP 1169059 20020109 | | Effective date | | | Applicant/owner | Aventis Pharma S.A., 20, avenue Raymond Aron
92165 Antony Cédex, FR | | Applicant ref. no. | | | Inventor | BELLET, Robert, E., 164 Black Cherry Circle
Elkins Park, PA 19027, US,
VOGEL, Charles LE., 5711 Hancock Road
Davie, FL 33330, US | | Representative | | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 31/335 (2006.01) , A61K 39/395 (2006.01) | | Title | Docetaxel i kombination med rhuMAb HER2 til behandling af cancere | | Int. application no. | US2000009247 | | Int. publication no. | WO2000061185 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
